Berenberg Bank Begins Coverage on Omega Healthcare Investors (NYSE:OHI)

Equities researchers at Berenberg Bank assumed coverage on shares of Omega Healthcare Investors (NYSE:OHI) in a research report issued to clients and investors on Friday, Briefing.com reports. The firm set a “buy” rating and a $45.00 price target on the real estate investment trust’s stock. Berenberg Bank’s price objective suggests a potential upside of 10.46% from the company’s previous close.

Several other equities research analysts also recently weighed in on the company. BMO Capital Markets increased their price objective on Omega Healthcare Investors from $44.00 to $45.00 and gave the company a “market perform” rating in a report on Monday, October 7th. Mizuho cut shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and increased their price target for the stock from $34.00 to $35.00 in a research note on Thursday, July 25th. Truist Financial raised their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research report on Wednesday, September 4th. Wells Fargo & Company reaffirmed an “overweight” rating and issued a $43.00 target price (up from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. Finally, Scotiabank raised their price target on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a report on Monday, August 26th. Eight analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $37.80.

Omega Healthcare Investors Price Performance

Shares of NYSE:OHI opened at $40.74 on Friday. The company has a debt-to-equity ratio of 1.19, a current ratio of 5.79 and a quick ratio of 5.79. Omega Healthcare Investors has a 12 month low of $27.53 and a 12 month high of $41.53. The firm has a market capitalization of $10.07 billion, a P/E ratio of 36.70, a P/E/G ratio of 1.28 and a beta of 1.00. The company’s fifty day moving average price is $39.64 and its 200 day moving average price is $35.16.

Omega Healthcare Investors (NYSE:OHI) last posted its earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 EPS for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.20). Omega Healthcare Investors had a return on equity of 8.61% and a net margin of 33.52%. The firm had revenue of $252.70 million for the quarter, compared to analyst estimates of $205.92 million. During the same quarter last year, the firm posted $0.74 EPS. The firm’s revenue for the quarter was up 17.5% on a year-over-year basis. As a group, sell-side analysts predict that Omega Healthcare Investors will post 2.69 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the transaction, the chief operating officer now directly owns 100,000 shares in the company, valued at approximately $4,025,000. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the sale, the chief financial officer now owns 183,076 shares of the company’s stock, valued at $7,357,824.44. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares of the company’s stock, valued at $4,025,000. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Omega Healthcare Investors

A number of large investors have recently bought and sold shares of the stock. Hennion & Walsh Asset Management Inc. increased its stake in shares of Omega Healthcare Investors by 96.7% during the 1st quarter. Hennion & Walsh Asset Management Inc. now owns 21,799 shares of the real estate investment trust’s stock valued at $690,000 after acquiring an additional 10,714 shares during the last quarter. Private Advisor Group LLC increased its position in Omega Healthcare Investors by 6.6% during the first quarter. Private Advisor Group LLC now owns 28,772 shares of the real estate investment trust’s stock worth $911,000 after purchasing an additional 1,783 shares during the last quarter. Park Avenue Securities LLC raised its stake in Omega Healthcare Investors by 5.7% during the first quarter. Park Avenue Securities LLC now owns 10,066 shares of the real estate investment trust’s stock worth $319,000 after purchasing an additional 544 shares during the period. Mather Group LLC. acquired a new position in shares of Omega Healthcare Investors in the 1st quarter valued at $116,000. Finally, Vanguard Group Inc. boosted its holdings in shares of Omega Healthcare Investors by 0.5% in the 1st quarter. Vanguard Group Inc. now owns 35,379,787 shares of the real estate investment trust’s stock valued at $1,120,478,000 after purchasing an additional 165,105 shares during the last quarter. Institutional investors and hedge funds own 65.25% of the company’s stock.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.